Ocular side effects of systemic medication


Cornea

Vortex keratopathy (cornea verticillata)

  • Signs: (a) fine greyish or golden-brown opacities in the inferior corneal epithelium, (b) progressing to a whorl-like pattern that originates from a point below the pupil and swirls outwards, sparing the limbus ( Fig. 20.1 ); usually reversible on cessation of medication. Vision is not impaired, but some patients may experience haloes.

    Fig 20.1

  • Causes: quinolone antimalarials (chloroquine, hydroxychloroquine) and amiodarone.

Chlorpromazine

Long-term therapy may cause subtle and visually innocuous yellowish-brown granular deposits in the endothelium, Descemet's membrane, and deep stroma.

Argyrosis

Keratopathy in argyrosis (silver deposition) is characterized by greyish-brown granular deposits in Descemet's membrane ( Fig. 20.2 ); conjunctival involvement may also occur ( Fig. 20.3 ).

Fig 20.2

Fig 20.3

Chrysiasis

Chrysiasis describes the deposition of gold in tissues after prolonged administration (chrysotherapy), usually in the treatment of rheumatoid arthritis. Keratopathy is characterized by asymptomatic dust-like or glittering purple granules scattered throughout the epithelium and stroma.

Amantadine

Soon after commencement of therapy, some patients develop reversible diffuse white punctate opacities sometimes associated with epithelial oedema.

Lens

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here